Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Sherman EA"'
Autor:
Hacein-Bey Abina S; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France2Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM, Paris, France3Unité de., Gaspar HB; Section of Molecular and Cellular Immunology, University College London Institute of Child Health, London, England6Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., Blondeau J; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France2Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM, Paris, France., Caccavelli L; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France2Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM, Paris, France., Charrier S; INSERM U951, Unité Mixte de Recherche S951, Molecular Immunology and Innovative Biotherapies, University of Evry, Evry, France8Genethon, Evry, France., Buckland K; Section of Molecular and Cellular Immunology, University College London Institute of Child Health, London, England6Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., Picard C; Centre d'Étude des Déficits Immunitaires, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France10Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France11Immunology and Pediatric Hematology Departmen., Six E; Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France12INSERM Unité Mixte de Recherche 1163, Laboratory of Human Lymphohematopoiesis, Paris, France., Himoudi N; Section of Molecular and Cellular Immunology, University College London Institute of Child Health, London, England6Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., Gilmour K; Section of Molecular and Cellular Immunology, University College London Institute of Child Health, London, England6Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., McNicol AM; Section of Molecular and Cellular Immunology, University College London Institute of Child Health, London, England6Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., Hara H; Section of Molecular and Cellular Immunology, University College London Institute of Child Health, London, England6Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., Xu-Bayford J; Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., Rivat C; Section of Molecular and Cellular Immunology, University College London Institute of Child Health, London, England6Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., Touzot F; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France2Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM, Paris, France10Paris D., Mavilio F; Genethon, Evry, France., Lim A; Groupe Immunoscope, Immunology Department, Institut Pasteur, Paris, France., Treluyer JM; Clinical Research Center Necker-Enfants Malades and Cochin Hospital Assistance Publique-Hôpitaux de Paris, Paris Descartes University., Héritier S; Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France11Immunology and Pediatric Hematology Department, Assistance Publique-Hôpitaux de Paris, Paris, France., Lefrère F; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France., Magalon J; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France2Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM, Paris, France., Pengue-Koyi I; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France2Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM, Paris, France10Paris D., Honnet G; Genethon, Evry, France., Blanche S; Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France11Immunology and Pediatric Hematology Department, Assistance Publique-Hôpitaux de Paris, Paris, France., Sherman EA; Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia., Male F; Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia., Berry C; Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia., Malani N; Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia., Bushman FD; Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia., Fischer A; Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France11Immunology and Pediatric Hematology Department, Assistance Publique-Hôpitaux de Paris, Paris, France12INSERM Unité Mixte de Recherche 1163, Laboratory of Human Lymphohematop., Thrasher AJ; Section of Molecular and Cellular Immunology, University College London Institute of Child Health, London, England6Department of Clinical Immunology, Hospital National Health Service Foundation Trust, London, England., Galy A; INSERM U951, Unité Mixte de Recherche S951, Molecular Immunology and Innovative Biotherapies, University of Evry, Evry, France8Genethon, Evry, France., Cavazzana M; Biotherapy Department, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France2Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM, Paris, France10Paris D.
Publikováno v:
JAMA [JAMA] 2015 Apr 21; Vol. 313 (15), pp. 1550-63.
Autor:
Hacein-Bey-Abina S; From the Departments of Biotherapy (S.H.-B.-A., J. Blondeau, L.C., F.T., M.C.) and Immunology and Pediatric Hematology (S.B., G.C., D.M., B.N., C.P., F.T., A.F.) and the Centre d'Étude des Déficits Immunitaires (C.P.), Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), the Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, AP-HP, INSERM (S.H.-B.-A., J. Blondeau, L.C., F.T., M.C.), Unité de Technologies Chimiques et Biologiques pour la Santé, Centre National de la Recherche Scientifique, 8258-INSERM Unité 1022, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes (S.H.-B.-A.), Immunology Laboratory, Groupe Hospitalier Universitaire Paris-Sud, AP-HP, Le Kremlin-Bicêtre (S.H.-B.-A.), Imagine Institute, Paris Descartes-Sorbonne Paris Cité University (S.B., J. Blondeau, L.C., D.M., B.N., C.P., E.S., A.F., M.C.), INSERM Unités Mixtes de Recherche 1163, Laboratory of Human Lymphohematopoiesis (J. Blondeau, L.C., E.S., F.T., A.F., M.C.), Groupe Immunoscope, Immunology Department, Institut Pasteur (A.L.), and Collège de France (A.F.) - all in Paris; Division of Hematology-Oncology (S.-Y.P., H.B., D.G., C.E.H., G.H., L.E.L., W.B.L., D.A.W.) and Division of Immunology (L.D.N.), Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute (S.-Y.P., D.G., L.E.L., W.B.L., D.A.W.), Harvard Medical School (S.-Y.P., M.A., L.E.L., W.B.L., J.R., L.E.S., A.T., L.D.N., D.A.W.), Center for Human Cell Therapy, Program in Cellular and Molecular Medicine, Boston Children's Hospital (M.A., J.R., L.E.S., A.T.), Division of Hematologic Malignancies, Dana-Farber Cancer Institute (J.R.), and the Manton Center for Orphan Disease Research (L.D.N.) - all in Boston; Great Ormond Street Hospital for Children NHS Foundation Trust (H.B.G., J.X.-B., A.J.T.) and Section of Molecular and Cellular Immunology, University College London Institute of Child Health (H.B.G., K.F.B., A., Pai SY, Gaspar HB, Armant M, Berry CC, Blanche S, Bleesing J, Blondeau J, de Boer H, Buckland KF, Caccavelli L, Cros G, De Oliveira S, Fernández KS, Guo D, Harris CE, Hopkins G, Lehmann LE, Lim A, London WB, van der Loo JC, Malani N, Male F, Malik P, Marinovic MA, McNicol AM, Moshous D, Neven B, Oleastro M, Picard C, Ritz J, Rivat C, Schambach A, Shaw KL, Sherman EA, Silberstein LE, Six E, Touzot F, Tsytsykova A, Xu-Bayford J, Baum C, Bushman FD, Fischer A, Kohn DB, Filipovich AH, Notarangelo LD, Cavazzana M, Williams DA, Thrasher AJ
Publikováno v:
The New England journal of medicine [N Engl J Med] 2014 Oct 09; Vol. 371 (15), pp. 1407-17.
A homozygous SLITRK6 nonsense mutation is associated with progressive auditory neuropathy in humans.
Autor:
Morlet T; Auditory Physiology and Psychoacoustics Research Laboratory, duPont Hospital for Children, Wilmington, Delaware, U.S.A., Rabinowitz MR, Looney LR, Riegner T, Greenwood LA, Sherman EA, Achilly N, Zhu A, Yoo E, O'Reilly RC, Jinks RN, Puffenberger EG, Heaps A, Morton H, Strauss KA
Publikováno v:
The Laryngoscope [Laryngoscope] 2014 Mar; Vol. 124 (3), pp. E95-103. Date of Electronic Publication: 2013 Dec 17.
Autor:
Kaplinsky NJ; Department of Biology, Swarthmore College, Swarthmore, Pennsylvania, United States of America., Gilbert SF, Cebra-Thomas J, Lilleväli K, Saare M, Chang EY, Edelman HE, Frick MA, Guan Y, Hammond RM, Hampilos NH, Opoku DS, Sariahmed K, Sherman EA, Watson R
Publikováno v:
PloS one [PLoS One] 2013 Jun 19; Vol. 8 (6), pp. e66357. Date of Electronic Publication: 2013 Jun 19 (Print Publication: 2013).
Autor:
Puffenberger EG; Clinic for Special Children, Strasburg, PA 17579, USA. epuffenberger@clinicforspecialchildren.org, Jinks RN, Wang H, Xin B, Fiorentini C, Sherman EA, Degrazio D, Shaw C, Sougnez C, Cibulskis K, Gabriel S, Kelley RI, Morton DH, Strauss KA
Publikováno v:
Human mutation [Hum Mutat] 2012 Dec; Vol. 33 (12), pp. 1639-46.
Autor:
Puffenberger EG; Clinic for Special Children, Strasburg, Pennsylvania, United States of America. epuffenberger@clinicforspecialchildren.org, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP, Cassidy RP, Fiorentini CJ, Heiken KF, Lawrence JJ, Mahoney MH, Miller CJ, Nair DT, Politi KA, Worcester KN, Setton RA, Dipiazza R, Sherman EA, Eastman JT, Francklyn C, Robey-Bond S, Rider NL, Gabriel S, Morton DH, Strauss KA
Publikováno v:
PloS one [PLoS One] 2012; Vol. 7 (1), pp. e28936. Date of Electronic Publication: 2012 Jan 17.
Autor:
Lohr NJ; Clinical Genetics and Metabolism, Department of Pediatrics, University of Colorado at Denver, Aurora, CO, USA., Molleston JP, Strauss KA, Torres-Martinez W, Sherman EA, Squires RH, Rider NL, Chikwava KR, Cummings OW, Morton DH, Puffenberger EG
Publikováno v:
American journal of human genetics [Am J Hum Genet] 2010 Mar 12; Vol. 86 (3), pp. 447-53. Date of Electronic Publication: 2010 Feb 18.
Autor:
Sherman EA; Ephrata High School, Ephrata, PA 17522, USA., Strauss KA, Tortorelli S, Bennett MJ, Knerr I, Morton DH, Puffenberger EG
Publikováno v:
American journal of human genetics [Am J Hum Genet] 2008 Nov; Vol. 83 (5), pp. 604-9.
Publikováno v:
eLife; 9/16/2024, p1-17, 17p
The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination.
Autor:
Hong Xi Liao, Xiaojun Mao, Lan Wang, Naijian Wang, Ocansey, Dickson Kofi Wiredu, Bo Wang, Fei Mao
Publikováno v:
Frontiers in Immunology; 2024, p1-17, 17p